PATENT CLAIM ANALYSIS

Application Number: 15861947
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["544", "262000"]

Abstract:
Provided is a salt having a high selectivity to BTK and is useful as a drug ingredient for a pharmaceutical product. It has been found that fumarate of Compound A is free of a characteristic of channel hydrate and is stable and excellent in absorptive property, compared to Compound A or other salts thereof.

Claim (Index 37):
The method of  claim 28 , wherein the fumarate is (R)-1-(1-acryloylpiperidin-3-yl)-4-amino-N-(benzo[d]oxazol-2-yl)-1H-pyrazolo[3,4-d]pyrimidine-3-carboxamide.monofumarate.

Metadata:
- Claim Count in Document: 92.0
- Percentile: 86.0
- Lexical Diversity: 1.35714
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15297180', '15748283', '15852280', '15130168', '15707508']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7877862555938537
- 35 USC 102 Novelty (BERT): 0.6710213849364739
- Combined Prediction Score: 0.7761097685281159
- Mean Citation Score: 389.266468
- Max Citation Score: 815.8483
- Similarity Product: 630.4749459776817

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test